ArticleScience translational medicine2021

Small-molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastoma.

Raelene Endersby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.